MSAC Evaluation Sub-Committee to meet next week
The Australian Government’s Medical Services Advisory Committee (MSAC) Evaluation Sub-Committee (ESC) is meeting next week to review and assess a range of MBS services.
MSAC advises the Government on evidence relating to the safety, effectiveness and cost-effectiveness of new and existing medical technologies and procedures. This advice is then used by the Government to make decisions about providing MBS funding for these procedures.
![](/sites/default/files/styles/limit_height/public/documents/ss36011.jpg?itok=-BdXFIyT)
This month, the Evaluation Sub-Committee is considering, among other things, the National Cervical Screening Program renewal; an HbA1c test for the diagnosis of diabetes mellitus; testing for Vitamin B12, Vitamin D and Folate; a review of interim funded breast MRI; palliative care consultation items; remote monitoring of patients with implanted cardiac devices; MRI for small bowel and pelvis in Crohn’s disease; catheter-based renal denervation for treatment-resistant hypertension; six genetic tests for the diagnosis of inheritable cardiac conduction disorders; and catheter-free ambulatory pH test for gastroesophageal reflux disease.